Lian-Shung Yeh

Frontline bevacizumab in ovarian clear cell versus high-grade serous ovarian cancer: survival outcomes and recurrence patterns in a real-world cohort

Ovarian clear cell carcinoma (OCCC) is associated with inferior survival compared to high-grade serous ovarian cancer (HGSOC), largely due to its relative chemoresistance and near-universal BRCA wild-type status. Whether frontline bevacizumab can mitigate this survival disadvanta...